-
Annual Report 2022: Time to move to the next stage2023-05-09 -
HA130- Improve the quality of life for dialysis pa...2023-03-23 -
Jafron Recognized as National Enterprise Technolog...2023-03-13 -
HA380 hemoperfusion cartridge-- Essential treatmen...2023-02-20 -
Golden Bull Award! Jafron Wins Golden Bull Award ...2023-02-08 -
Expert Consensus on Artificial Liver Therapy2023-01-18 -
Mr. Jean Paul Menneguerre, Senior Head of the EMEA...2023-01-12 -
Jafron in Jordan: Facilitator of the Local Healthc...2023-01-11 -
ESICM: Getting to Know Jafron from Different Persp...2023-01-11
-
Annual Report 2022: Time to move to the next stage2023-05-09
-
HA130- Improve the quality of life for dialysis patients2023-03-23
-
Jafron Recognized as National Enterprise Technology Center2023-03-13
-
HA380 hemoperfusion cartridge-- Essential treatments for critical illness2023-02-20
-
Golden Bull Award! Jafron Wins Golden Bull Award for Highest Investment Value o...2023-02-08
-
Expert Consensus on Artificial Liver Therapy2023-01-18
-
Mr. Jean Paul Menneguerre, Senior Head of the EMEA markets of Jafron Biomedical ...2023-01-12
-
Jafron in Jordan: Facilitator of the Local Healthcare Industry2023-01-11
-
ESICM: Getting to Know Jafron from Different Perspectives2023-01-11
Jafron Biomedical Co., Ltd.
Address : No. 98 Technology Six Road, High-tech Zone, Zhuhai City, China
E-mail : customerservice@jafron.com
Website : https://www.jafroninternational.com
Terms of Use｜Site Map｜ Cookie Notice｜ Privacy Notice
Recruitment Privacy Notice｜ 7/24 Hotline
© 2016 Jafron Biomedical Co., Ltd. All rights reserved.
